Engineering a synthetic niche for hADSC preconditioning with PRP, Lp-SN, and resveratrol nanoparticles
Source abstract
Abstract
Ex vivo expansion of human adipose-derived stem cells (hADSCs) remains challenging because reduced-serum culture conditions can compromise short-term cell function. Here, we evaluated a microenvironment-inspired tri-component preconditioning regimen composed of platelet-rich plasma (PRP), Lactobacillus plantarum cell-free supernatant (Lp-SN), and resveratrol-loaded PLGA nanoparticles (RSV-PLGA-NPs) as a reduced-serum culture support strategy. Using a Box-Behnken design, we identified a formulation space in which PRP, Lp-SN, and RSV-PLGA-NPs were associated with improved hADSC viability and increased expression of selected stemness-associated genes in vitro. Omission-control experiments comparing the full formulation with partial combinations and blank PLGA NPs showed attenuated responses when individual components were removed, whereas the NP carrier alone had no significant effect. These findings support the utility of this tri-component system as a preliminary ex vivo preconditioning approach for short-term hADSC culture support. However, the results should be interpreted within the limits of the present in vitro study, as long-term expansion, post-treatment differentiation capacity, and in vivo performance were not evaluated.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Mesenchymal stem cell research · Tissue Engineering and Regenerative Medicine · Cancer Cells and Metastasis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Microbiology, Ar.C, Islamic Azad University
Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences
Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine
References (55)
Show source-provided references
1. 10.1016/j.cej.2021.13252310.1016/j.cej.2021.132523 ↗
2. 10.1002/jcp.3008510.1002/jcp.30085 ↗
3. 10.1186/s12906-023-03952-710.1186/s12906-023-03952-7 ↗
4. 10.2144/btn-2022-011210.2144/btn-2022-0112 ↗
5. 10.1016/s0301-472x(00)00160-010.1016/s0301-472x(00)00160-0 ↗
6. 10.1186/s12967-021-03125-510.1186/s12967-021-03125-5 ↗
7. 10.1039/d2tb00279e10.1039/d2tb00279e ↗
8. 10.7150/ijms.11565010.7150/ijms.115650 ↗
9. 10.3389/fcell.2023.132367810.3389/fcell.2023.1323678 ↗
10. 10.3389/fcell.2020.0036410.3389/fcell.2020.00364 ↗
11. 10.1186/s13287-015-0217-810.1186/s13287-015-0217-8 ↗
12. 10.1007/s11999-015-4179-z10.1007/s11999-015-4179-z ↗
13. 10.1002/stem.13910.1002/stem.139 ↗
14. 10.1186/s12864-024-10329-810.1186/s12864-024-10329-8 ↗
15. Ullah Q, et al. Efficacy prediction of Lactobacillus rhamnosus GG and Platelet-Rich Plasma (PRP) against Sub-Clinical Bubaline Mastitis. Pak Vet J. 2023;43(4):2074–7764.
16. 10.1016/j.bbrc.2014.01.08410.1016/j.bbrc.2014.01.084 ↗
17. 10.1371/journal.pone.006492310.1371/journal.pone.0064923 ↗
18. 10.1016/j.biopha.2023.11435610.1016/j.biopha.2023.114356 ↗
19. 10.1186/s13018-020-01684-910.1186/s13018-020-01684-9 ↗
20. 10.1002/jcp.2834210.1002/jcp.28342 ↗
21. 10.1080/0886022X.2022.202948810.1080/0886022X.2022.2029488 ↗
22. 10.1007/s13577-023-00989-110.1007/s13577-023-00989-1 ↗
23. 10.18502/ajmb.v15i2.1201710.18502/ajmb.v15i2.12017 ↗
24. 10.1080/21691401.2016.124645210.1080/21691401.2016.1246452 ↗
25. 10.1007/s12015-023-10658-310.1007/s12015-023-10658-3 ↗
26. 10.1016/j.molcel.2012.06.02010.1016/j.molcel.2012.06.020 ↗
27. 10.1038/s41419-025-08094-x10.1038/s41419-025-08094-x ↗
28. 10.1186/s13287-016-0352-x10.1186/s13287-016-0352-x ↗
29. Demir A Aslim B. Investigation of multifaceted wound healing effect of exopolysaccharide (EPS) produced from probiotic strain Lactiplantibacillus plantarum GD2 as in vitro and in ovo. 2024.10.21203/rs.3.rs-4058404/v1 ↗
30. 10.30476/ijms.2019.4577210.30476/ijms.2019.45772 ↗
31. 10.1089/ten.TEC.2024.016910.1089/ten.TEC.2024.0169 ↗
32. 10.1128/aem.00608-2310.1128/aem.00608-23 ↗
33. 10.3389/fmicb.2022.86472010.3389/fmicb.2022.864720 ↗
34. 10.1038/s41598-025-90682-010.1038/s41598-025-90682-0 ↗
35. 10.1016/j.tice.2023.10209110.1016/j.tice.2023.102091 ↗
36. 10.1016/j.jnutbio.2023.10950510.1016/j.jnutbio.2023.109505 ↗
37. 10.3920/BM2017.011810.3920/BM2017.0118 ↗
38. 10.3389/fmicb.2023.128789910.3389/fmicb.2023.1287899 ↗
39. Ghosh AR. Probiotics-associated extracellular vesicles in health and diseases. In: Ghosh AR, editor. Extracellular vesicles in human health and diseases. Singapore: Springer; 2024.10.1007/978-981-97-2494-9 ↗
40. 10.1016/j.neuint.2017.10.00210.1016/j.neuint.2017.10.002 ↗
41. 10.18632/aging.10136110.18632/aging.101361 ↗
42. 10.1016/j.bbrc.2015.10.01710.1016/j.bbrc.2015.10.017 ↗
43. 10.1038/s41419-018-0914-110.1038/s41419-018-0914-1 ↗
44. 10.1002/stem.181110.1002/stem.1811 ↗
45. 10.3389/fbioe.2025.144653710.3389/fbioe.2025.1446537 ↗
46. 10.3390/coatings1005043910.3390/coatings10050439 ↗
47. 10.3389/fmolb.2021.64939510.3389/fmolb.2021.649395 ↗
48. 10.1098/rsos.18145710.1098/rsos.181457 ↗
49. 10.1016/j.heliyon.2023.e1945210.1016/j.heliyon.2023.e19452 ↗
50. 10.1590/1678-4324-202221023110.1590/1678-4324-2022210231 ↗
51. 10.1186/s13287-023-03578-z10.1186/s13287-023-03578-z ↗
52. 10.1186/s13287-020-1569-210.1186/s13287-020-1569-2 ↗
53. 10.15283/ijsc2410710.15283/ijsc24107 ↗
54. 10.1016/j.ijrobp.2024.03.00310.1016/j.ijrobp.2024.03.003 ↗
55. 10.3389/fimmu.2023.128544210.3389/fimmu.2023.1285442 ↗